Bharat Immunological & Biologicals Corporation Ltd. - Research Center
524663 BIBCL Group (B) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Sep' 23 |
Jun' 23 |
Mar' 23 |
Dec' 22 |
Sep' 22 |
Sales |
- |
- |
7.65 |
- |
26.48 |
Operating profit |
-4.69 |
-4.31 |
-6.41 |
-4.73 |
-2.50 |
Interest |
2.09 |
1.72 |
2.05 |
1.67 |
1.74 |
Gross profit |
-6.61 |
-5.93 |
-6.22 |
-6.29 |
-3.92 |
EPS (Rs) |
-1.14 |
-1.06 |
-0.99 |
-1.08 |
-0.71 |
Quarterly
results in details
|
Sep' 23 |
Jun' 23 |
Mar' 23 |
Dec' 22 |
Sep' 22 |
Other income |
0.16 |
0.10 |
2.24 |
0.10 |
0.32 |
Stock adjustment |
- |
- |
7.84 |
-7.83 |
24.27 |
Raw material |
- |
- |
- |
6.51 |
0.11 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
3.98 |
3.90 |
3.31 |
4.10 |
3.95 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
0.71 |
0.42 |
2.90 |
1.95 |
0.65 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.03 |
0.03 |
0.04 |
0.04 |
0.04 |
Taxation |
-1.73 |
-1.38 |
-1.97 |
-1.65 |
-0.88 |
Net profit / loss |
-4.92 |
-4.59 |
-4.29 |
-4.68 |
-3.08 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
43.18 |
43.18 |
43.18 |
43.18 |
43.18 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
- |
- |
-83.79 |
- |
-9.44 |
GPM (%) |
- |
- |
-62.94 |
- |
-14.64 |
NPM (%) |
- |
- |
-43.42 |
- |
-11.50 |